Avanir Pharma says higher dose of Zenvia reduced number of emotional outbursts tied to disease

Avanir posts mixed late stage Zenvia study results

ALISO VIEJO, Calif. — Avanir Pharmaceuticals Inc. on Friday reported mixed results for its drug candidate Zenvia, which is intended to reduce involuntary emotional outbursts in patients with neurological disorders.

Shares of Acorda Therapeutics dive after FDA questions experimental multiple sclerosis drug

Acorda shares plunge on negative FDA review

WASHINGTON — Shares of Acorda Therapeutics plummeted Friday after the Food and Drug Administration issued a negative opinion that questioned the safety and effectiveness of the company’s multiple sclerosis drug.

FDA says it confirmed new cases of brain inflammation linked to MS drug, bringing total to 13

FDA confirms 3 new infections linked to Tysabri

NEW YORK — The Food and Drug Administration says it confirmed three new cases of a potentially lethal brain inflammation linked to the multiple sclerosis drug Tysabri.

Prof _ and mother _ creates program to keep chronically ill students in college

School gives chronically ill students a chance

CHICAGO — Cecilia Reyes stepped onto the auditorium stage, a bit unsteadily. Her legs were tired. She was so nervous, she hardly smiled.